Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
Titel:
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
Auteur:
Jerusalem, Guy Prat, Aleix Salgado, Roberto Reinisch, Mattea Saura, Cristina Ruiz-Borrego, Manuel Nikolinakos, Petros Ades, Felipe Filian, Jeiry Huang, Ning Mazzei-Abba, Antonella Tolaney, Sara M.